Key facts
- This page summarizes Marvin Slosman's Form 4 filing for InspireMD, Inc. (NSPR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 May 2026, 17:00.
Marvin Slosman - 12 May 2026 Form 4 Insider Report for InspireMD, Inc. (NSPR)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- NSPR
- Reported as of
- 12 May 2026
- Net transaction value
- +$25,200
- SEC form
- 4
- Accepted by SEC
- 13 May 2026, 17:00:17 UTC
- Prior SEC filing
- 16 Jan 2026
- Next SEC filing
- 07 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Lawless, Attorney-in-Fact for Marvin Slosman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marvin Slosman filed Form 4 for InspireMD, Inc. (NSPR) on 13 May 2026.
Change
- Previous filing in this sequence was filed on 16 Jan 2026.
- Current net transaction value: +$25,200.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001796908
Primary reporting owner
Slosman Marvin
- Relationship
- CEO and President, Director
- Address
- C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI
- Signature
- /s/ Michael Lawless, Attorney-in-Fact for Marvin Slosman
- Signature date
- 13 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NSPR
transaction
Common Stock
Purchase
- Transaction value
- $25,200
- Shares
- +21,000
- Change %
- +0.59%
- Price
- $1.20
- Shares after
- 3,556,658
- Date
- 12 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.